Kellogg Co.’s stock price rose over 5 percent immediately following its announcement that it will be splitting into three companies, focused on snacks, plant-based foods, and breakfast cereal.
Wall Street analysts claim that even though the stock dropped again after the Kellogg announcement, food equities as a whole increased.
The method employed by Kellogg fits into a developing pattern of increased snack intake. According to Mintel data, half of the consumers between the ages of 35 and 54 believe that snacking is healthier than eating three meals regularly throughout the day.
Sales for Kellogg's snacks division were $11.4 billion last year, much above those of the other two spinoff units.
The breakup of Kellogg has also sparked interest in comparable actions among large food corporations with broad product lines. As smaller units become more nimble to adapt to trends and events, such actions typically acquire flexibility.
The trade-off is that, in some situations, the smaller businesses do not profit as much from economies of scale as the larger ones did.


Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth
Tesla Faces 19% Drop in UK Registrations as Competition Intensifies
Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data 



